| Lukas Küng. Immunomodulation by epigenetically activated endogenous retroelements in ovarian cancer. 2025 |
| Katja Rungger. Intratumoral microorganisms and their effects on antitumor immunity. 2024 |
| Elena Frisch. Analysis of signaling responses to kinase inhibitors using mouse organoids. 2023 |
| Matthias Winkler. Immunogenic cell death by kinase inhibitor treatment of tumor organoids. 2023 |
| Marie Theres Elling. Molecular and metabolic characterization of cancer associated fibroblasts. 2022 |
| Leonie Madersbacher. Effects of PARP inhibition on the transcriptome in BRCA1 wild-type and BRCA1 deficient ovarian cancer cell lines. 2022 |
| Gabriel Floriani. Viral and tumour associated antigen prediction for a variety of class I HLA alleles. 2022 |
| Stefanie Estermann. Histological and metabolic characterization of murine CRC organoids. 2022 |
| Leonie Madersbacher. Synthetic lethal interactions determine the therapeutic vulnerability of cancer. 2021 |
| Valentin Marteau. Combining a systems biology approach with a model of in vitro human cortical brain development to study schizophrenia. 2020 |
| Hendrik Gottschling. Immune independent analysis of tumour sample transcriptomes. 2020 |
| Markus Ausserhofer. Development and validation of a pipeline for tumor epitope prediction. 2020 |
| Matthias Leitner. Neoepitope prediction for personalized cancer immunotherapy. 2020 |
| Verena Vogi. Influence of metabolic processes, individual metabolites and nutrients on T-Cell responses. 2019 |
| Nina Huber. Investigating the role of the nuclear receptor NR4A1 in T cell activation and T cell glucose metabolism. 2019 |
| Niloofar Nemati. Investigation of the role of nuclear receptor activity in the cytotoxic T cell activation - exhaustion axis. 2019 |
| Sophia Daum. Development of an in vitro system for testing drug combinations. 2019 |
| Yeliz Cengiz. Establishment of a drug treatment protocol fro organoid derived from colorectal cancer of human patients. 2019 |
| Christoph Schatz. Development of an analysis tool to identify cancer type specific microRNA targets. 2019 |
| Johannes Ruepp. Analysis of histone and protein acetylation in human adipocytes. 2016 |
| Christina Plattner. Gene and microRNA expression based molecular cancer classification. 2015 |
| Benno Weber. Modeling cancer metabolism. 2015 |
| Clemens Mayer. Modelling cancer stem cells. 2014 |
| Dominik Schweiger. SPARQL Graph: Graphical query builder for biological federated SPARQL queries. 2014 |
| Stefan Scondo. Evaluation of next generation sequencing analysis techniques |
| Alvaro Ospina. Development of a chemotaxis model for tumor-immune cell interaction. 2013 |
| Matthias Baldauf. Development of an application for management of high content images. 2013 |
| Michaela Willi. Mapping expression data onto genome-scale human metabolic models. 2012 |
| Prioritization of disease driving candidate genes based on various public data sources in the context of rare Mendelian diseases |
| GPU computing and its practical applications in a HPC infrastructure for Clinical Bioinformatics |
